About Us
Company
Journey So Far
Board of Directors
Our Expertise
Manufacturing
Research & Development
Quality Assurance & Regulatory Affairs
Products
Business
CDMO Services and Products
Domestic Branded Generics
International Branded Generics
Investor Relations
Financial Results
Annual Financial Statements
Annual Reports
Investor Resources/Information
Corporate Governance
Share Price Information
Sustainability
Corporate Social Responsibilities
Environment, Health & Safety
Environmental, Social & Governance
ESG Profile
Careers
Contact
Investor Relations
Annual Financial Statements
Financial Statements
-
2025-26
Revised Standalone
Revised Consolidated
2024-25
Standalone
Consolidated
2023-24
Standalone
Consolidated
2022-23
Standalone
Consolidated
2021-22
Standalone
Consolidated
2020-21
Standalone
2019-20
Standalone
2018-19
Standalone
Univentis Medicare Limited
+
Revised Financial Statements 2025-26
Financial Statements 2024-25
Financial Statements 2023-24
Financial Statements 2022-23
Financial Statements 2021-22
Financial Statements 2020-21
Financial Statements 2019-20
Financial Statements 2018-19
Sharon Bio-Medicine Limited
+
Revised Financial Statements 2025-26
Financial Statements 2024-25
Financial Statements 2023-24
Financial Statements 2022-23
Univentis Foundation
+
Financial Statements 2025-26
Financial Statements 2024-25
Financial Statements 2023-24
Financial Statements 2022-23
